跳至主要内容
临床试验/CTRI/2025/09/094430
CTRI/2025/09/094430尚未招募2 期

An Exploratory Study To Compare The Effect Of Madhudaka And Triyushnadi Mantha In The Management Of Atisthoulya (Obesity)

PREETI CHAUHAN1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年12月18日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
REDUCTION IN SIGN AND SYMPTOMS OF ATISTHOULYA BY DECREASING BMI BREATHLESSNESS SNORING

研究概览

简要总结

AN EXPLORATRY STUDY WILL BE DONE ON TWO GROUPS EACH CONSISTING 30 PATIENTS. ONE GROUP WILL BE ADMINISTERED MADHUDAKA IN QUANTITY OF 2 PAL OR 96GMS O.D. AND OTHER GROUP WILL BE ADMINISTERED TRIYUSHNADI MANTHA IN QUANTITY OF 2 PAL OR 96GMS O.D. FOR 45 DAYS. THEN PATIENTS WILL BE ASSESS BEFORE AND AFTER THE TRIAL ON THE BASIS OF SUBJECTIVE AND OBJECTIVE CRITERIA OF ATISTHOULYA AND FOLLOW UP WILL BE DONE EVERY 15TH DAY. THE DATA WILL BE COLLECTED AND ANALYZED STATISTICALLY USING APPROPRIATE TESTS.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • The Patient Age Between 16-65 Years Irrespective Of Their Caste, Race And Sex Etc.
  • BMI Greater Than 25 And Above.
  • The Patient Having Clinical Signs & Symptoms Of Obesity.
  • The Patient Should Not Be On Any Other Medicine For Atisthoulya.

排除标准

  • Patient With Endocrinal Disorder (D.M.) And Other Systemic Disease.
  • Patient With Long Term Steroid Treatment.
  • The Patient Having Obesity With Secondary In Origin.
  • Pregnant Women Drug Induced Obesity.
  • Patient Who Has BMI Less Then 25.

结局指标

主要结局

REDUCTION IN SIGN AND SYMPTOMS OF ATISTHOULYA BY DECREASING BMI BREATHLESSNESS SNORING

时间窗: SIX WEEKS

次要结局

  • IMPROVEMENT IN SUBJECTIVE AND OBJECTIVE ASSESSMENT CRITERIA OF ATISTHOULYA SUCH AS LESSER BMI(45 DAYS)

研究者

发起方
PREETI CHAUHAN
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

DR SAURABH AGARWAL

PGIA JODHPUR

研究点 (1)

Loading locations...

相似试验